MT activates mechano-transduction signaling pathways, induces mitochondria biogenesis signaling and diminishes the levels of inflammatory cytokines, such as the interleukin IL-6 and TNF (tumor necrosis factor)-α [52], changes that could benefit FM and CFS/ME patients [53,54]. Here, IL6 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.